Results 131 to 140 of about 72,335 (302)

Amiodarone and hair loss [PDF]

open access: bronze, 1992
Leslie Samuel, MWJ Davie, Ian R. Starkey
openalex   +1 more source

Catheter Ablation Is Associated With a Decrease in Major Adverse Cardiovascular Events and All‐Cause Mortality in Patients With Atrial Fibrillation and Obstructive Sleep Apnea

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction Obstructive sleep apnea (OSA) is a common risk factor for the development and progression of atrial fibrillation (AF). Whether catheter ablation for AF management in patients with coexisting OSA yields survival benefit remains unclear.
Ghassan Bidaoui   +16 more
wiley   +1 more source

A Rare Case Report of Amiodarone-Induced Bone Marrow Granuloma

open access: yesAnnals of Internal Medicine: Clinical Cases
Amiodarone has rarely been reported to induce bone marrow granulomas. In this case, we describe the case of a 67-year-old man who was incidentally found to have pancytopenia while receiving amiodarone therapy for 18 months.
Sunpil Hwang   +3 more
doaj   +1 more source

Outcomes of Focused Double Extrastimuli Mapping and Ablation in Ventricular Tachycardia

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Conventional substrate mapping for scar‐related ventricular tachycardia (VT) often fails to fully delineate critical arrhythmogenic components. Functional mapping strategies using extrastimuli have shown promise but are limited by procedural complexity.
Surachat Jaroonpipatkul   +6 more
wiley   +1 more source

Single-chamber Versus Dual-chamber Implantable Cardioverter Defibrillators: Do We Need Physiologic Pacing in The Course? [PDF]

open access: yes, 2006
Background: Many patients with ICD receive different antiarrhythmic drugs (e.g. sotalol, amiodarone, β-blockers) because of ventricular or atrial tachycardias.
Buck, Thomas   +4 more
core   +2 more sources

Effects of soluble guanylyl cyclase stimulation on muscle oxygenation and exercise capacity in heart failure with mildly reduced ejection fraction

open access: yesExperimental Physiology, EarlyView.
Abstract Heart failure (HF) with a mildly reduced ejection fraction (HFmrEF; 40%–49%) is present in ≤25% of HF patients. Therapeutic treatment options for HFmrEF‐associated exercise intolerance are limited. Nitric oxide (NO)‐independent stimulation of soluble guanylyl cyclase to improve peripheral vasodilatation offers a novel approach to enhance ...
Ramona E. Weber   +10 more
wiley   +1 more source

In silico predictions of action potential propagation in doxorubicin cardiotoxicity: A parametric study using preclinical 3D magnetic resonance imaging‐based fibrotic left ventricle models

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Schematic overview of the study's methodology and key findings. In a preclinical swine model, doxorubicin administration induced cardiotoxicity, characterized by diffuse fibrotic remodelling and altered electrical function, as assessed by magnetic resonance (MR) imaging and electrophysiological mapping.
Javier Villar‐Valero   +7 more
wiley   +1 more source

Mechanisms of Hepatocellular Toxicity Associated with Dronedarone—A Comparison to Amiodarone [PDF]

open access: yes, 2017
Dronedarone is a new antiarrhythmic drug with an amiodarone-like benzofuran structure. Shortly after its introduction, dronedarone became implicated in causing severe liver injury. Amiodarone is a well-known mitochondrial toxicant.
Blum, Kim   +4 more
core  

Mechanistic insights into sex differences in atrial electrophysiology and arrhythmia vulnerability through sex‐specific computational models

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Sex‐specific models of the human atrial myocyte in normal sinus rhythm (nSR) and chronic atrial fibrillation (cAF) revealed increased alternans susceptibility in cAF males and DADs in females, driven primarily by ICaL and ryanodine receptor remodelling.
Nathaniel T. Herrera   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy